RedHill Biopharma Ltd. (RDHL) — Institutional Holders, Q2 2026
14 institutional investment managers reported a RDHL position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $270.0K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
RDHL in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSAdded · +44,648 sh+$37.7K
- Lido AdvisorsNew · +11,009 sh+$9.3K
- RHUMBLINE ADVISERSAdded · +8,639 sh+$7.3K
- CITIGROUPNew · +4,378 sh+$3.7K
- GAMMA InvestingAdded · +273 sh+$231.00
Biggest sellers
- Yorkville Advisors GlobalTrimmed · -228,739 sh-$193.3K
- XTX Topco LtdSold out · -15,163 sh-$12.8K
- StoneX GroupSold out · -14,481 sh-$12.2K
- TWO SIGMA SECURITIESSold out · -13,019 sh-$11.0K
- UBS Group AGTrimmed · -726 sh-$614.00
RDHL 13F holders ranked 1–14 of 14
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Yorkville Advisors Global#1 · 122,131 sh | 122,131 | $106.7K | 0.12% | -65.2% |
| 2 | GAGNON SECURITIES#2 · 88,405 sh | 88,405 | $74.7K | 0.01% | 0.0% |
| 3 | CITADEL ADVISORS#3 · 65,321 sh | 65,321 | $55.2K | 0.00% | +216.0% |
| 4 | RHUMBLINE ADVISERS#4 · 13,755 sh | 13,755 | $11.6K | 0.00% | +168.9% |
| 5 | Lido Advisors#5 · 11,009 sh | 11,009 | $9.3K | 0.00% | New |
| 6 | GAMMA Investing#6 · 6,957 sh | 6,957 | $5.9K | — | +4.1% |
| 7 | CITIGROUP#7 · 4,378 sh | 4,378 | $3.7K | 0.00% | New |
| 8 | Federation des caisses Desjardins du Quebec#8 · 3,388 sh | 3,388 | $2.9K | 0.00% | 0.0% |
| 9 | UBS Group AG#9 · 100 sh | 100 | $85.00 | 0.00% | -87.9% |
| 10 | SBI Securities , Ltd.#10 · 15 sh | 15 | $13.00 | — | +275.0% |
| 11 | Smartleaf Asset Management#11 · 5 sh | 5 | $4.00 | 0.00% | 0.0% |
| 12 | Vermillion Wealth Management#12 · 2 sh | 2 | $2.00 | — | 0.0% |
| 13 | MORGAN STANLEY#13 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
| 14 | ROYAL BANK OF CANADA#14 · 351 sh | 351 | $0.00 | 0.00% | New |
Funds that sold out of RDHL in Q2 2026 (4)
Held RDHL at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XTX Topco Ltd15,163 sh | 15,163 | $11.3K |
| StoneX Group14,481 sh | 14,481 | $10.8K |
| TWO SIGMA SECURITIES13,019 sh | 13,019 | $9.7K |
| Your Advocates Ltd., LLP19 sh | 19 | $14.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.